Genital and urinary tract infections in diabetes: Impact of pharmacologically-induced glucosuria
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Predisposition to genital infections and urinary tract infections (UTIs) in type 2 diabetes mellitus (T2DM) results from several factors such as glucosuria, adherence of bacteria to the uroepithelium and immune dysfunction. The tendency to develop these infections could be even higher in patients with T2DM treated with the emerging class of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Studies have shown that pharmacologically-induced glucosuria with SGLT2 inhibitors raises the risk of developing genital infections and, to a relatively lesser extent, UTIs. However, a definitive dose relationship of the incidence of these infections with the SGLT2 doses is not evident in the existing data. Therefore, the precise role of glucosuria as a causative factor for these infections is yet to be fully elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicolle, L. E., Bradley, S., Colgan, R., Rice, J. C., Schaeffer, A., & Hooton, T. M. (2005) · Clinical Infectious Diseases · doi:10.1086/427507 · Cited by 1,601
Impaired Leucocyte Functions in Diabetic Patients
Delamaire, M., Maugendre, D., Moreno, M., Le Goff, M.-C., Allannic, H., & Genetet, B. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199701)14:1<29::aid-dia300>3.0.co;2-v · Cited by 1,074
Bolinder, J., Ljunggren, Ö., Kullberg, J., Johansson, L., Wilding, J., Langkilde, A. M., Sugg, J., & Parikh, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2260 · Cited by 867
Self-citationBailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60407-2 · Cited by 860
Self-citationCefalu, W. T., Leiter, L. A., Yoon, K.-H., Arias, P., Niskanen, L., Xie, J., Balis, D. A., Canovatchel, W., & Meininger, G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60683-2 · Cited by 724
Ferrannini, E., Ramos, S. J., Salsali, A., Tang, W., & List, J. F. (2010) · Diabetes Care · doi:10.2337/dc10-0612 · Cited by 716
Self-citationSodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
List, J. F., Woo, V., Morales, E., Tang, W., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc08-1863 · Cited by 698
Self-citationSchernthaner, G., Gross, J. L., Rosenstock, J., Guarisco, M., Fu, M., Yee, J., Kawaguchi, M., Canovatchel, W., & Meininger, G. (2013) · Diabetes Care · doi:10.2337/dc12-2491 · Cited by 480
Rosenstock, J., Vico, M., Wei, L., Salsali, A., & List, J. F. (2012) · Diabetes Care · doi:10.2337/dc11-1693 · Cited by 408
Self-citationStrojek, K., Yoon, K. H., Hruba, V., Elze, M., Langkilde, A. M., & Parikh, S. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01434.x · Cited by 406
Self-citationKomoroski, B., Vachharajani, N., Feng, Y., Li, L., Kornhauser, D., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.250 · Cited by 396
Wilding, J. P. H., Norwood, P., T'joen, C., Bastien, A., List, J. F., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc09-0517 · Cited by 363
Self-citationWu, X. R., Sun, T. T., & Medina, J. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9630 · Cited by 342
Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
Benfield, T., Jensen, J. S., & Nordestgaard, B. G. (2007) · Diabetologia · doi:10.1007/s00125-006-0570-3 · Cited by 331
Henry, R. R., Murray, A. V., Marmolejo, M. H., Hennicken, D., Ptaszynska, A., & List, J. F. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02911.x · Cited by 310
Self-citationBACTERIAL URINARY TRACT INFECTIONS IN DIABETES
Patterson, J. E., & Andriole, V. T. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70383-4 · Cited by 294
Handicaps to Host Defense: Effects of Hyperglycemia on C3 and Candida albicans
Hostetter, M. K. (1990) · Diabetes · doi:10.2337/diab.39.3.271 · Cited by 270
Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes
de Leon, E. M., Jacober, S. J., Sobel, J. D., & Foxman, B. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-1 · Cited by 248
Geerlings, S. E., Stolk, R. P., Camps, M. J., Netten, P. M., Hoekstra, J. B., Bouter, K. P., Bravenboer, B., Collet, J. T., Jansz, A. R., & Hoepelman, A. I. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.744 · Cited by 232
Self-citationRosenstock, J., Seman, L. J., Jelaska, A., Hantel, S., Pinnetti, S., Hach, T., & Woerle, H. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12185 · Cited by 214
Risk factors for symptomatic urinary tract infection in women with diabetes.
Geerlings, S. E., Stolk, R. P., Camps, M. J., Netten, P. M., Collet, T. J., Hoepelman, A. I., & Diabetes Women Asymptomatic Bacteriuria Utrecht Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1737 · Cited by 185
Self-citationFerrannini, E., Seman, L., Seewaldt‐Becker, E., Hantel, S., Pinnetti, S., & Woerle, H. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12081 · Cited by 181
Hirji, I., Guo, Z., Andersson, S. W., Hammar, N., & Gomez-Caminero, A. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.008 · Cited by 172
Bailey, C. J., Iqbal, N., T'joen, C., & List, J. F. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01659.x · Cited by 167
Self-citationHOEPELMAN, A. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00234-6 · Cited by 162
Cytokine secretion is impaired in women with diabetes mellitus
Geerlings, S. E., Brouwer, E. C., van Kessel, K. P. M., Gaastra, W., Stolk, R. P., & Hoepelman, A. I. M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00745.x · Cited by 155
Self-citationPrevalence of clinical vaginal candidiasis in a university hospital and possible risk factors
Grigoriou, O., Baka, S. G., Makrakis, E., Hassiakos, D., Kaparos, G., & Kouskouni, E. E. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.09.015 · Cited by 152
Nyirjesy, P., Zhao, Y., Ways, K., & Usiskin, K. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.697053 · Cited by 148
Nicolle, L. E., Friesen, D., Harding, G. K. M., & Roos, L. L. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.1051 · Cited by 147
Asymptomatic Bacteriuria in Patients with Diabetes Mellitus
Zhanel, G. G., Harding, G. K. M., & Nicolle, L. E. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.5.150 · Cited by 146
Goswami, R., Dadhwal, V., Tejaswi, S., Datta, K., Paul, A., Haricharan, R. N., Banerjee, U., & Kochupillai, N. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0723 · Cited by 146
Kaku, K., Inoue, S., Matsuoka, O., Kiyosue, A., Azuma, H., Hayashi, N., Tokudome, T., Langkilde, A. M., & Parikh, S. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12047 · Cited by 135
Self-citationAdherence of Type 1-Fimbriated Escherichia coli to Uroepithelial Cells
Geerlings, S. E., Meiland, R., van Lith, E. C., Brouwer, E. C., Gaastra, W., & Hoepelman, A. I. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1405 · Cited by 131
Self-citationMeta-Analysis of the Significance of Asymptomatic Bacteriuria in Diabetes
Renko, M., Tapanainen, P. J., Tossavainen, P. H., Pokka, T. M.-L., & Uhari, M. K. (2010) · Diabetes Care · doi:10.2337/dc10-0421 · Cited by 128
Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients.
Cartón, J. A., Maradona, J. A., Mateo, F. J. N., Fernandez-Alvarez, R., Pérez-González, F., & Asensi (1992) · PubMed · Cited by 111
Hirji, I., Andersson, S. W., Guo, Z., et al. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.012 · Cited by 99
Ribera, M. C., Pascual, R., Orozco‐Beltrán, D., Barba, C., Pedrera, V., & Gil, V. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0148-5 · Cited by 96
Nicolle, L. E., Capuano, G. A., Ways, K., & Usiskin, K. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.689956 · Cited by 79
Segal, E., Soroka, A., & Schechter, A. (1984) · Medical Mycology · doi:10.1080/00362178485380321 · Cited by 74
Asymptomatic Bacteriuria in Women With Diabetes Mellitus
Meiland, R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2222 · Cited by 73
Schwartz, S. L., Akinlade, B., Klasen, S., Kowalski, D. L., Zhang, W., & Wilpshaar, W. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0012 · Cited by 70
Neutrophil Sorbitol Production Impairs Oxidative Killing in Diabetes
Wilson, R. M., Tomlinson, D. R., & Reeves, W. G. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00825.x · Cited by 63
Diversity and complexity of urinary tract infection in diabetes mellitus
Hakeem, L. M., Bhattacharyya, D., Lafong, C., Janjua, K., Serhan, J. T., & Campbell, I. W. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409105654 · Cited by 25
Cited by
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
“The main side effect of SGLT2 inhibitors was an increased risk of genitourinary infections [42].”
BackgroundUeda, P., Svanström, H., Melbye, M., Eliasson, B., Svensson, A.-M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., & Pasternak, B. (2018) · BMJ · doi:10.1136/bmj.k4365 · Cited by 367
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Vallon, V. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-110046 · Cited by 348
Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
Madsbad, S. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12596 · Cited by 305
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Tentolouris, A., Vlachakis, P., Tzeravini, E., Eleftheriadou, I., & Tentolouris, N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16162965 · Cited by 300
“The higher urine glucose levels due to the glycosuric effect of SGLT2i, predisposes patients to urinary tract and genital infections [140].”
Background
Metadata
- Authors
- Geerlings, S., Fonseca, V., Castro-Diaz, D., List, J., & Parikh, S.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 103
- Issue
- 3
- Pages
- 373-381
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2100796772
- Cited by
- 274
- References
- 43
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.